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Divergent and chemoselective transformations of thioamides with 
designed carbene equivalents 
Masato Saito, [a] Yusuke Kobayashi, [a] Yoshiji Takemoto*[a] 
 
Abstract: The reactions of thioamides with ortho-nitro-substituted 
iodonium ylides proceeded under mild conditions to give 
enaminones or thiazoles, depending on the iodonium ylide used. 
This protocol allowed the use of protic solvents, including aqueous 
solutions, and therefore coupling reactions with complex molecules 
such as peptides or steroids were possible. A mild and efficient 
method for the synthesis of various iodonium ylides was established. 
A DFT calculation suggested that halogen bonding between a 
thioamide and iodonium ylide was important in this chemoselective 
coupling reaction. The potential use of enaminones conjugated with 
pharmaceuticals as prodrugs was also demonstrated. 
Thioamides have attracted much attention because they are 
isosteres of amides, but with higher lipophilicities and stabilities. 
Many studies of peptides and proteins with thioamide moieties 
have been conducted.[1] An increasing number of methods for 
the introduction of thioamides at desired positions of peptides 
are being developed.[2] In addition, thioamides have high 
nucleophilicities and their selective transformations have 
recently been studied. [3] In particular, the reactions of thioamide 
groups, which are rarely found in biomolecules, have potential 
applications in chemoselective bioconjugation, which is one of 
the most important tools for drug discovery and in chemical 
biology. [4,5] However, only a few examples of such reactions 
have been reported. These reports include transition-metal-
catalyzed coupling reactions with carbene equivalents. [5] Use of 
diazomalonates as carbene precursors gave enaminones 
(Scheme 1A, eq. 1), [5d–f] whereas thiazoles were obtained when 
-diazo ketoesters were used as the carbene precursors 
(Scheme 1A, eq. 2). [5b,c] Both products were supposedly 
obtained through C‒S bond formation. Although enaminones[6] 
and thiazoles[7] are both attractive pharmacophores with specific 
properties, these reactions generally require high temperatures 
because of the formation of inert complexes through thioamide 
coordination to the metal catalyst. It is therefore difficult to apply 
these reactions to heat-labile molecules such as proteins. 
Undesired O–H insertion[8] of metal carbenoids into polar 
solvents such as alcohols also prevents thioamide use with 
complex molecules, which are difficult to dissolve in non-polar 
solvents.  
Herein, we report a highly chemoselective coupling reaction of 
various thioamides with a variety of carbene equivalents in protic 
solvent under mild conditions. We therefore focused on 
iodonium ylides (Scheme 1A, eqs. 3,4) as carbene equivalents[9] 
because hypervalent iodine compounds, including iodonium 
ylides, have recently been reported to have σ-holes, [10] and they 
are expected to form halogen bonds (XB) [11,12] selectively with 
soft Lewis bases[13] such as thioamides, even in the presence of 
a polar functional group such as an alcohol. However, the use of 
iodonium ylides as electrophiles (Scheme 1A, eq. 4) has been 
less studied [14,15] than metal carbenoid precursors (Scheme 1A, 
eq. 3). This limitation is because of the poor solubility and 
instability of iodonium ylides, and side reactions such as 
nucleophile dimerization (Scheme 1A, eq. 5). The strongly basic 
conditions needed for their preparation[9b,16] also hinders the 
synthesis of a range of iodonium ylides. 
 
Scheme 1. Summary of this work 
 To solve these problems, we focused on the effects of ortho 
substituents on the solubility and stability of iodonium 
ylides[14b,17] and hypervalent iodine compounds. [18] We 
envisaged that introduction of an ortho substituent would 
decrease side reactions by blocking one of the σ-holes, and cis-
selective coordination of thioamide to iodonium ylide would 
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promote C‒S bond formation (Scheme 1B, eqs. 7,8). In 
particular, the introduction of an ortho nitro group would enhance 
the reactivity of the corresponding precursor, ArI(III)(OAc)2, 
which would enable condensations with various active 
methylene compounds under mild conditions to produce 
iodonium ylides with broad functional group tolerance (Scheme 
1B, eq.6). We also envisioned the application of the method to 
enaminone-based prodrug (Scheme 1B, eq. 9) and thiazole-
tethered conjugation of two complex molecules. 
 
 
Table 1. Optimization of reaction conditions for chemoselective 




Catalyst Solvent Yield (%)[a] 
1 3 Rh2(OAc)4 CH3OH N.D.
[b] 
2 3 CuBr CH3OH N.D.
[b] 
3 3 Grubbs’ 1st CH3OH N.D.
[b] 
4 4 none CH3OH 48 
5 5a none CH3OH 81 
6 6 none CH3OH 28 
7 5a none CH3OH 71
[c] 
8 5a none toluene 82 
9 5a none THF 84 
10 5a none DMF 79 
11 5a none DMF/H2O 71 
 
[a] Isolated yields  [b]  Not detected. [c] 1.0 equiv of TEMPO was added. 
 
 
First, we screened the reaction conditions by using the 
glutamine-derived thioamide 1a as the substrate (Table 1). 
When the reaction was conducted in methanol at 0 ºC, the 
addition of a metal catalyst, i.e., Rh2(OAc)4, CuBr, or Grubbs’ 
first generation catalyst, with diazomalonate 3 as the metal 
carbenoid precursor, no reaction occurred (Table 1, entries 1–3). 
The use of iodonium ylide 4, with a methoxymethyl group at the 
ortho position, gave the desired enaminone 2a in 48% yield 
(Table 1, entry 4). Finally, an ortho nitro-substituted iodonium 
ylide 5a was found to be the best reagent to furnish 2a in 81% 
yield (Table 1, entry 5). A significant drop in the yield and many 
unidentified byproducts were observed when the simple 
iodonium ylide 6 was used (Table 1, entry 6). These results 
strongly indicate the importance of ortho substitution of the 
aromatic ring of iodonium ylides. In this reaction, the addition of 
TEMPO as a radical scavenger did not significantly decrease the 
yield (Table 1, entry 7), suggesting that a radical intermediate 
would not be involved in the reaction mechanism. The effect of 
the solvent was then studied (Table 1, entries 8–11). When non-
polar solvents such as toluene and THF were used, enaminone 
2a was obtained in 82% and 84% yields, respectively (Table 1, 
entries 8 and 9). Notably, aqueous media and DMF, which are 
often used to dissolve complex molecules, gave the desired 
product in good yields (Table 1, entries 10 and 11).  
 
Figure 1. Substrate scope for synthesis of enaminones. 
With the optimum reaction condition in hand, we investigated the 
substrate scope of the reaction between thioamides and a nitro- 
substituted iodonium ylide (Figure 1). Various primary 
thioamides were tolerated in the reaction with iodonium ylides. 
Thioamides derived from glycinamide and oleamide gave 
enaminones in 71% and 81% yields, respectively (Figure 1, 2a, 
2c). This reaction was also applicable to a substrate with an 
azide moiety (2d), which could potentially be used for further 
functionalization via nitrene insertion[19] or click reactions[20] in 
the presence of a metal catalyst. Although enaminone 2e was 
obtained from cyclohexanethiocarboamide in 62% yield, 
desulfurization did not occur when thiopivaloylamide was used, 
because of steric hindrance, and thiazole 2f was obtained in 
67% yield. This reaction can also be conducted with the 
thioasparagine residue of a dipeptide (2g), indicating the 
potential of this method for late-stage functionalization of more 
complex peptides with thioamide moieties. This reaction was 
then applied to secondary thioamides. The desired enaminone 
was obtained in 79% yield from the simple thioanilide 2h. The 
reactions with secondary thioamides were performed at room 
temperature. A substrate with thioamide moieties as the main 





peptide chain gave the target product 2i in 98% yield. Finally, 
this reaction was applied to the functionalization of 
pharmaceuticals. The thioamide derived from the aromatase 
inhibitor aminoglutethimide, [21] which has been used as the 
second- or third-line choice in the treatment of hormone-
sensitive metastatic breast cancer, reacted with 5a to give 
enaminone 2l in 92% yield. It is worth mentioning that the 
reaction proceeded even when alkyne functional groups were 
present, which could be further functionalized with azide-
containing probes or biomolecules through the orthogonal click 
reaction. [20] 
 
Scheme 2. Release of aminoglutethimide 
To demonstrate the utility of this reaction, the selective cleavage 
of this enaminone moiety for the potential prodrug applications 
was investigated (Scheme 2). The reaction of enaminone 2l, 
which contained aminoglutethimide, in an acidic solvent 
released aminoglutethimide almost quantitatively.[6] The poor 
pharmacokinetics of aminoglutethimide[21b] might be improved by 
functionalization based on this methodology. 
 
Figure 2. Substrate scope for synthesis of iodonium ylides 
We next investigated the transformation of a -ketoester-derived 
iodonium ylide to a thiazole by coupling with a thioamide (Figure 
2,3). We envisioned that this thiazole synthesis could be used to 
link complex molecules via thiazole pharmacophores. This 
strategy requires the introduction of complex molecules into 
iodonium ylides. However, the conditions generally used to 
access iodonium ylides (e.g., use of KOH or KOMe in methanol 
or acetonitrile) would lead to decomposition or epimerization of 
complex molecules. After various screenings of solvents, bases, 
and additives, we identified the appropriate reaction conditions 
for the preparation of various iodonium ylides (Figure 2). A 
mixture of 2-iodobenzene diacetate 7, an active methylene 
compound 8 (1.1 or 2.0 equiv), 2,6-lutidine (5.0 equiv), and 
hexafluoro-2-propanol (HFIP) (2.0 equiv) in acetonitrile at 0 ºC 
gave the corresponding iodonium ylides in moderate to excellent 
yields. [22] This method gave the dimethyl malonate-derived 
iodonium ylide in 78% yield (Figure 2, 5a). As well as diester-
containing iodonium ylides, ketoester-containing iodonium ylides 
were synthesized. The product derived from tert-butyl 
acetoacetate was obtained in 62% yield (5b). Complex 
molecules such as diosgenin and dipeptides (5c and 5d) were 
synthesized without any decomposition or epimerization, in 80% 
and 56% yields, respectively. These iodonium ylides were stable 
even when subjected to silica-gel column chromatography, 
presumably because of the ortho effect. Iodonium ylides bearing 
a protected sugar moiety (5e) or an alkyne group (5f) were 
synthesized under these reaction conditions.  
 
Figure 3. Substrate scope for synthesis of thiazoles 
We then investigated the reactions of the above prepared 
functionalized iodonium ylides 5a‒f with thioamides to give 
thiazoles (Figure 3). When the iodonium ylides were reacted 
with oleamide derivatives, the desired thiazole 9 was obtained in 
62% yield, although the addition of acetic acid was required for 
dehydration. We then conducted the reaction with complex 
iodonium ylides 5c–e, bearing diosgenin, dipeptide, and sugar 
moieties. These ylides were effectively converted to the 





corresponding thiazoles (10–12) in 59%, 42%, and 66% yield, 
respectively. An alkyne group was also tolerated under the 
reaction conditions. Finally, we tried to use the reaction to 
introduce a sugar into a peptide. Iodonium ylide 5e reacted 
rapidly with the thioasparagine residue of a dipeptide to furnish 
the desired thiazole 14 in 57% yield. The introduction of the 
sugar moiety could improve the physical properties of the 
bioactive molecules, and this example showed the potential of 
this method for achieving conjugation of two complex molecules. 
 
Figure 4. (A) transition state for C‒S bond formation and (B) complexation of 
iodonium ylides and thioamides 
To gain the insight into the reaction mechanism, DFT 
calculations were performed with a thioacetamide and the 
iodonium ylide derived from methyl acetoacetate as model 
substrates, including the effects of ortho substituents on 
iodonium ylides (Figure 4). A three-atom-centered transition 
state[13a,b] was proposed for C‒S bond formation (Figure 4A); the 
calculation was performed with Gaussian 09[23] at the B97D/6-
31G (d,p) level[24] and the DGDZVP basis set[25] was used for 
iodine. Regardless of the ortho substituent, the calculated 
activation energies for C‒S bond formation were ca. 20 kcal/mol 
in all cases (Figure S5, S6), [22] suggesting that the ortho 
substituent on the iodonium ylide did not affect the activation 
energies. More importantly, the results suggest that both 
hydrogen bonding and halogen bonding promoted complexation 
of the thioamide and iodonium ylide to give the intermediate Int 
1ANO2 before the C‒S bond-forming step. In the absence of an 
ortho substituent, several optimized structures were obtained, 
presumably because the halogen-bond-donating ylide σ*C‒I 
orbital is readily accessible by the thioamide (Int 1BH), and the 
aromatic ring of the iodonium ylide is sufficiently flexible for the 
thioamide to readily interact with the carbonyl moiety of the 
iodonium ylide through hydrogen bonding (Int 1CH). These 
intermediates could lead to side reactions such as dimerization. 
These results suggest that the ortho nitro substituent would 
control the coordination mode (Figure S1‒S3), [22] leading to 
selective formation of the desired C‒S bond rather than lowering 
the activation energy of C‒S bond formation.   
In conclusion, we have developed a chemoselective reaction of 
thioamides with iodonium ylides. Halogen-bonding interactions 
between the species are responsible for the high 
chemoselectivity and wide functional group tolerance in polar 
solvents. In addition, the ortho substituent on the iodonium 
ylides can control the coordination mode of the nucleophile via 
-holes, suppressing undesired side reactions. These findings 
would enhance chemoselective coupling reactions using 
hypervalent iodine compounds. This improved method for 
iodonium ylide preparation will also enable the development and 
expansion of carbenoid chemistry. A detailed mechanistic study 
and investigation of applications of this reaction in 
bioconjugation are underway in our laboratory. 
Experimental Section 
To a solution of thioamide 1a (17.6 mg, 0.05 mmol) in MeOH (1.0 mL) 
was added iodonium ylide 5a (28.4 mg, 0.075 mmol) at the indicated 
temperature. After being stirred at the same temperature for 12 hours, 
the crude mixture was directly purified by preparative TLC (Eluent: n-
hexane/EtOAc = 75/25) to give desired products 2a (18.2 mg, 81%). 
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The reactions of thioamides with ortho-nitro-substituted iodonium ylides proceeded 
under mild conditions to give enaminones or thiazoles. This protocol allowed the 
use of protic solvents, including aqueous solutions, and therefore coupling reactions 
with complex molecules were possible. A mild and efficient method for the 
synthesis of various iodonium ylides was also established.  
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